Estrogen receptor beta modulates permeability transition in brain mitochondria

Biochim Biophys Acta Bioenerg. 2018 Jun;1859(6):423-433. doi: 10.1016/j.bbabio.2018.03.006. Epub 2018 Mar 14.

Abstract

Recent evidence highlights a role for sex and hormonal status in regulating cellular responses to ischemic brain injury and neurodegeneration. A key pathological event in ischemic brain injury is the opening of a mitochondrial permeability transition pore (MPT) induced by excitotoxic calcium levels, which can trigger irreversible damage to mitochondria accompanied by the release of pro-apoptotic factors. However, sex differences in brain MPT modulation have not yet been explored. Here, we show that mitochondria isolated from female mouse forebrain have a lower calcium threshold for MPT than male mitochondria, and that this sex difference depends on the MPT regulator cyclophilin D (CypD). We also demonstrate that an estrogen receptor beta (ERβ) antagonist inhibits MPT and knockout of ERβ decreases the sensitivity of mitochondria to the CypD inhibitor, cyclosporine A. These results suggest a functional relationship between ERβ and CypD in modulating brain MPT. Moreover, co-immunoprecipitation studies identify several ERβ binding partners in mitochondria. Among these, we investigate the mitochondrial ATPase as a putative site of MPT regulation by ERβ. We find that previously described interaction between the oligomycin sensitivity-conferring subunit of ATPase (OSCP) and CypD is decreased by ERβ knockout, suggesting that ERβ modulates MPT by regulating CypD interaction with OSCP. Functionally, in primary neurons and hippocampal slice cultures, modulation of ERβ has protective effects against glutamate toxicity and oxygen glucose deprivation, respectively. Taken together, these results reveal a novel pathway of brain MPT regulation by ERβ that could contribute to sex differences in ischemic brain injury and neurodegeneration.

Keywords: Calcium; Cyclophilin D; Estrogen receptor; Mitochondria; Permeability transition.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Triphosphatases / genetics*
  • Adenosine Triphosphatases / metabolism
  • Animals
  • COS Cells
  • Calcium / metabolism
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Chlorocebus aethiops
  • Cyclophilins / antagonists & inhibitors
  • Cyclophilins / deficiency
  • Cyclophilins / genetics*
  • Cyclosporine / pharmacology
  • Estrogen Receptor beta / antagonists & inhibitors
  • Estrogen Receptor beta / deficiency
  • Estrogen Receptor beta / genetics*
  • Female
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Male
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potential, Mitochondrial / physiology
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microtomy
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondrial Membrane Transport Proteins / genetics*
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Mitochondrial Proton-Translocating ATPases
  • Peptidyl-Prolyl Isomerase F
  • Piperidines / pharmacology
  • Prosencephalon / drug effects
  • Prosencephalon / metabolism*
  • Protein Binding
  • Pyrazoles / pharmacology
  • Sex Factors
  • Tissue Culture Techniques

Substances

  • 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole
  • Carrier Proteins
  • Peptidyl-Prolyl Isomerase F
  • Estrogen Receptor beta
  • Membrane Proteins
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • PPIF protein, mouse
  • Piperidines
  • Pyrazoles
  • Cyclosporine
  • Adenosine Triphosphatases
  • Mitochondrial Proton-Translocating ATPases
  • Cyclophilins
  • oligomycin sensitivity-conferring protein
  • Calcium